These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7505707)

  • 21. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis use in palliative care - an examination of the evidence and the implications for nurses.
    Green AJ; De-Vries K
    J Clin Nurs; 2010 Sep; 19(17-18):2454-62. PubMed ID: 20920073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective review of specialist palliative care involvement in motor neurone disease.
    Ryan R; Tracey G; Lawlor P; O'Siorain L; Higgins S
    Ir Med J; 2012; 105(10):335-8. PubMed ID: 23495545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Motor neuron disease: primary lateral sclerosis and amyotrophic lateral sclerosis].
    Martić V
    Vojnosanit Pregl; 2000; 57(2):205-8. PubMed ID: 10934934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palliative care and taboos within motor neurone disease.
    O'Brien T
    Palliat Med; 1993; 7(4 Suppl):69-72. PubMed ID: 7505713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotrophic factors in the treatment of motor neuron disease and trauma.
    DiStefano PS
    Exp Neurol; 1993 Nov; 124(1):56-9. PubMed ID: 8282081
    [No Abstract]   [Full Text] [Related]  

  • 29. Motor neuron disease.
    Jackson CE; Rosenfeld J
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):335-52, ix-x. PubMed ID: 11345011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best".
    Mitsumoto H; Rabkin JG
    JAMA; 2007 Jul; 298(2):207-16. PubMed ID: 17622602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Living with amyotrophic lateral sclerosis/motor neurone disease (ALS/MND): decision-making about 'ongoing change and adaptation'.
    King SJ; Duke MM; O'Connor BA
    J Clin Nurs; 2009 Mar; 18(5):745-54. PubMed ID: 19239541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding psycho-social processes underpinning engagement with services in motor neurone disease: a qualitative study.
    Foley G; Timonen V; Hardiman O
    Palliat Med; 2014 Apr; 28(4):318-25. PubMed ID: 24637571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social services homecare for people with motor neurone disease/amyotrophic lateral sclerosis: why are such services used or refused?
    O'Brien MR; Whitehead B; Murphy PN; Mitchell JD; Jack BA
    Palliat Med; 2012 Mar; 26(2):123-31. PubMed ID: 21383059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Will ciliary neurotrophic factor slow progression of motor neuron disease?
    Longo FM
    Ann Neurol; 1994 Aug; 36(2):125-7. PubMed ID: 8053646
    [No Abstract]   [Full Text] [Related]  

  • 35. Funding agencies and disease organizations: resources and recommendations to facilitate ALS clinical research.
    Chad DA; Bidichandani S; Bruijn L; Capra JD; Dickie B; Ferguson J; Figlewicz D; Forsythe M; Kaufmann P; Kirshner A; Monti W
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14 Suppl 1():62-6. PubMed ID: 23678881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor neuron disease associated with copper deficiency.
    Weihl CC; Lopate G
    Muscle Nerve; 2006 Dec; 34(6):789-93. PubMed ID: 16929546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALS: life and death in a bad neighborhood.
    Monk PN; Shaw PJ
    Nat Med; 2006 Aug; 12(8):885-7. PubMed ID: 16892030
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of trophic factors in degenerative motoneuron diseases.
    Yan Q; Miller JA
    Exp Neurol; 1993 Nov; 124(1):60-3. PubMed ID: 8282082
    [No Abstract]   [Full Text] [Related]  

  • 39. Dying at home: a way of maintaining control for the person with ALS/MND.
    Moore MK
    Palliat Med; 1993; 7(4 Suppl):65-8. PubMed ID: 7505712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor unit firing in amyotrophic lateral sclerosis and other upper and lower motor neurone disorders.
    de Carvalho M; Turkman A; Swash M
    Clin Neurophysiol; 2012 Nov; 123(11):2312-8. PubMed ID: 22627021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.